Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF2B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MLH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACYP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZC2HC1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS6KL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PROX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YLPM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FCF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on